MD Earnings Prediction
The chart below shows how MD performed 10 days before and after its earnings report, based on data from the past quarters. Typically, MD sees a +3.94% change in stock price 10 days leading up to the earnings, and a -3.20% change 10 days following the report. On the earnings day itself, the stock moves by -0.98%. This data can give you a slight idea of what to expect for the next quarter's release.
MD Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
511.16M
0.90%
1.36%
Gross Margin
--
--
--
Operating Margin
10.26%
29.06%
6.10%
Net Margin
3.80%
-9.95%
-112.52%
EPS
0.23
-11.54%
-112.50%
No Data Available
MD Earnings Analysis
Pediatrix Medical Group, Inc. Corporation (MD.N) Earnings Conference Call
Positive
Q3 Operating Results Improvement: Our third quarter operating results were modestly ahead of expectations, driven primarily by same unit revenue growth.
Stable Patient Volumes: Patient volumes were stable to positive across all of our core service lines compared to the third quarter of last year.
NICU and Pediatric Growth: On the hospital-based side, our NICU days rose modestly, reflecting slightly positive total births and we saw positive comparisons across newborn nursery, pediatric intensive care and peds hospitalist services.
Hybrid Revenue Cycle Transition: During the quarter, we successfully completed the final wave of our transition to a hybrid revenue cycle management structure, and I am pleased that not only is the transition behind us, but we were able to complete it without any meaningful disruptions to our operating results.
Operating Cash Flow Increase: We generated $96 million in operating cash flow during the third quarter compared to $81 million in the prior year.
Negative
MD FAQs
How does MD typically perform around its earnings report dates?
Is Pediatrix Medical Group, Inc. (MD) Q3 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
MD Earning Call Sentiment
Pediatrix Medical Group, Inc. (MD) Q3 2024 Earnings Call Transcript
1.0x
00:00
00:00
MD.N
1.71%Positive
The earnings call presents a mixed picture. Financial performance shows modest revenue growth and improved cash flow, but increased G&A expenses and unclear RCM benefits raise concerns. The restructuring plan and reduced net debt are positives, yet the conservative EBITDA guidance and lack of clarity in the Q&A suggest uncertainty. Without a market cap, the impact is hard to gauge, but the overall sentiment leans towards a neutral stock price reaction over the next two weeks.
